We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, ti... Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator. Show more
Viking Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update PR Newswire SAN DIEGO, April 24, 2024 Conference call scheduled for 4:30 p.m. ET today Results From...
U.S. index futures are showing mixed results in pre-market trading this Wednesday, as investors assess the latest financial results released. As of 6:31 AM, Dow Jones Industrial Average futures...
Viking Therapeutics to Report Financial Results for First Quarter 2024 on April 24, 2024 PR Newswire SAN DIEGO, April 17, 2024 Conference Call Scheduled for Wednesday, April 24 at 4:30 p.m...
Viking Therapeutics Announces Results from Phase 1 Clinical Trial of Oral Tablet Formulation of Dual GLP-1/GIP Receptor Agonist VK2735 PR Newswire SAN DIEGO, March 26, 2024 Up to 3.3...
Viking Therapeutics Announces Closing of Public Offering of Common Stock Including Full Exercise of Underwriters' Option to Purchase Additional Shares PR Newswire SAN DIEGO, March 4, 2024 SAN...
Viking Therapeutics Announces Pricing of $550 Million Public Offering of Common Stock PR Newswire SAN DIEGO, Feb. 28, 2024 SAN DIEGO, Feb. 28, 2024 /PRNewswire/ -- Viking Therapeutics, Inc...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 4.32 | 6.69352339634 | 64.54 | 69.1348 | 61.64 | 2547697 | 65.5496715 | CS |
4 | -13.11 | -15.9936562157 | 81.97 | 82 | 61.64 | 2605802 | 70.94625289 | CS |
12 | 44.98 | 188.358458961 | 23.88 | 99.3999 | 22.51 | 6708628 | 70.99302477 | CS |
26 | 59.86 | 665.111111111 | 9 | 99.3999 | 8.28 | 4522922 | 54.24220528 | CS |
52 | 48.89 | 244.817225839 | 19.97 | 99.3999 | 8.28 | 3479563 | 41.10842698 | CS |
156 | 62.8 | 1036.30363036 | 6.06 | 99.3999 | 2.02 | 2247896 | 25.27802016 | CS |
260 | 60.49 | 722.700119474 | 8.37 | 99.3999 | 2.02 | 1887493 | 19.98954592 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions